231 related articles for article (PubMed ID: 21777616)
1. Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor.
Joo EJ; Kang CI; Ha YE; Kim J; Kang SJ; Park SY; Lee NY; Wi YM; Chung DR; Peck KR; Song JH
J Infect; 2011 Sep; 63(3):207-14. PubMed ID: 21777616
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
[TBL] [Abstract][Full Text] [Related]
3. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
Kang CI; Chung DR; Peck KR; Song JH;
Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
[TBL] [Abstract][Full Text] [Related]
6. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S
Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
Martínez B; Gómez J; Gómez Vargas J; Gómez JR; Baños V; Sánchez ME; Canteras M; Valdés M
Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
[TBL] [Abstract][Full Text] [Related]
8. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
Lee CC; Lee CH; Hong MY
Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
12. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
Sligl W; Taylor G; Brindley PG
Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
[TBL] [Abstract][Full Text] [Related]
13. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
[TBL] [Abstract][Full Text] [Related]
14. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
Tuon FF; Gortz LW; Rocha JL
Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
[TBL] [Abstract][Full Text] [Related]
17. Different clinical presentation of community-onset bacteremia among neutropenic adults in the ED.
Lee CC; Hsieh CC; Lee NY; Chan TY; Hong MY; Chi CH; Ko WC
Am J Emerg Med; 2015 Jul; 33(7):907-12. PubMed ID: 25959847
[TBL] [Abstract][Full Text] [Related]
18. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
19. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s.
Maschmeyer G; Braveny I
Eur J Clin Microbiol Infect Dis; 2000 Dec; 19(12):915-25. PubMed ID: 11205628
[TBL] [Abstract][Full Text] [Related]
20. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
